Paul L Bollyky Selected Research

Hyaluronic Acid (Hyaluronan)

4/2022	Biochemical, Biophysical, and Immunological Characterization of Respiratory Secretions in Severe SARS-CoV-2 (COVID-19) Infections.
1/2022	Biochemical, biophysical, and immunological characterization of respiratory secretions in severe SARS-CoV-2 infections.
1/2022	IL-10 promotes endothelial progenitor cell infiltration and wound healing via STAT3.
10/2021	Interleukin-10 Producing T Lymphocytes Attenuate Dermal Scarring.
8/2021	Biochemical and Biophysical Characterization of Respiratory Secretions in Severe SARS-CoV-2 (COVID-19) Infections.
2/2021	Modulation of hyaluronan synthases and involvement of T cell-derived hyaluronan in autoimmune responses to transplanted islets.
1/2020	High-molecular weight hyaluronan attenuates tubulointerstitial scarring in kidney injury.
10/2019	4-Methylumbelliferyl glucuronide contributes to hyaluronan synthesis inhibition.
1/2019	Adenosine and hyaluronan promote lung fibrosis and pulmonary hypertension in combined pulmonary fibrosis and emphysema.
1/2019	Hyaluronan levels are increased systemically in human type 2 but not type 1 diabetes independently of glycemic control.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul L Bollyky Research Topics

Disease

16	Inflammation (Inflammations) 10/2021 - 09/2009
12	Infections 04/2022 - 07/2007
12	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2021 - 02/2010
10	Wounds and Injuries (Trauma) 01/2022 - 01/2015
7	Cystic Fibrosis (Mucoviscidosis) 04/2022 - 11/2015
7	Fibrosis (Cirrhosis) 10/2021 - 01/2017
5	Spasm (Spasms) 01/2022 - 01/2015
4	COVID-19 04/2022 - 08/2021
4	Cicatrix (Scar) 10/2021 - 11/2019
3	Inborn Genetic Diseases (Disease, Hereditary) 04/2022 - 08/2021
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 01/2019
3	Pulmonary Hypertension 01/2022 - 10/2017
3	Hypersensitivity (Allergy) 01/2021 - 01/2018
3	Lung Injury 01/2019 - 01/2017
3	Multiple Sclerosis 01/2017 - 01/2015
2	Neoplasms (Cancer) 04/2022 - 01/2015
2	Lung Diseases (Lung Disease) 01/2022 - 01/2019
2	Persistent Infection 01/2021 - 01/2020
2	Bacterial Infections (Bacterial Infection) 01/2019 - 01/2018
1	Necrosis 04/2022
1	Superinfection 01/2022
1	Febrile Neutropenia 01/2022
1	Breast Neoplasms (Breast Cancer) 02/2021
1	Erythema 01/2021
1	Pain (Aches) 01/2021
1	Ischemia 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Ureteral Obstruction 01/2020
1	Suppurative Otitis Media 01/2020
1	Hyperglycemia 01/2019
1	Hemorrhage 01/2019
1	Emphysema 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Obesity 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Respiratory Hypersensitivity 01/2017
1	Confusion (Bewilderment) 01/2017
1	Gliosis 01/2017
1	Demyelinating Diseases (Demyelinating Disease) 01/2017
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 02/2016

Drug/Important Bio-Agent (IBA)

25	Hyaluronic Acid (Hyaluronan)IBA 04/2022 - 07/2007
10	CytokinesIBA 10/2021 - 01/2017
8	Interleukin-10 (Interleukin 10)IBA 01/2022 - 01/2013
6	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2017
6	Pharmaceutical PreparationsIBA 01/2022 - 01/2015
6	GlycosaminoglycansIBA 01/2022 - 08/2014
5	HymecromoneIBA 01/2022 - 01/2015
4	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 01/2020
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2010
4	CollagenIBA 10/2021 - 11/2019
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2020
3	Deoxyribonucleases (DNase)FDA Link 04/2022 - 08/2021
3	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 04/2022 - 08/2021
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2012
3	PolymersIBA 01/2019 - 11/2015
2	ChemokinesIBA 01/2022 - 11/2015
2	erucylphosphocholineIBA 01/2022 - 09/2015
2	HydrogelsIBA 01/2021 - 01/2019
2	Heparitin Sulfate (Heparan Sulfate)IBA 01/2020 - 12/2018
2	InterleukinsIBA 01/2020 - 02/2010
2	Hyaluronan SynthasesIBA 01/2019 - 10/2017
2	Polysaccharides (Glycans)IBA 02/2016 - 10/2015
1	Versicans (Versican)IBA 04/2022
1	Cell Surface ReceptorsIBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2021
1	Interleukin-2 (IL2)IBA 01/2021
1	Minocycline (Cyclops)FDA LinkGeneric 01/2021
1	Dihydrotachysterol (AT 10)IBA 01/2020
1	phosphomannopentaose sulfateIBA 01/2020
1	4-methylumbelliferyl glucuronideIBA 10/2019
1	thiocyanateIBA 01/2019
1	Heparin (Liquaemin)FDA LinkGeneric 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2019
1	AutoantigensIBA 01/2019
1	Antiviral Agents (Antivirals)IBA 01/2019
1	Adenosine (Adenocard)FDA LinkGeneric 01/2019
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2019
1	Insulin (Novolin)FDA Link 12/2018
1	Crystallins (Crystallin)IBA 01/2017
1	Immunoglobulin E (IgE)IBA 01/2017
1	AllergensIBA 01/2017
1	CuprizoneIBA 01/2017
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2017
1	Small Heat-Shock ProteinsIBA 01/2017
1	OvalbuminIBA 01/2017
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2017

Therapy/Procedure

5	Therapeutics 01/2022 - 01/2018
3	Phage Therapy 01/2021 - 01/2018
2	Reoperation 01/2020 - 03/2011
1	Surgical Amputation (Amputations) 01/2021
1	Injections 01/2021
1	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2021
1	Replacement Arthroplasty 01/2020
1	Oral Administration 10/2019
1	Glycemic Control 01/2019
1	Arthroplasty 01/2018
1	Investigational Therapies (Experimental Therapy) 01/2017